A comment on 'the impact of statins, ace inhibitors and gastric acid suppressants on pneumonia mortality in a UK general practice population cohort'.
Nam-Kyong
NK
Choi
Yoosoo
Y
Chang
Byung-Joo
BJ
Park
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D005744:Gastric Acid / Q000378:metabolism; D006635:Histamine H2 Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D009026:Mortality / Q000639:trends; D011014:Pneumonia / Q000401:mortality* / Q000517:prevention & control; D054328:Proton Pump Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D006113:United Kingdom / Q000453:epidemiology
D000806:Angiotensin-Converting Enzyme Inhibitors; D006635:Histamine H2 Antagonists; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D054328:Proton Pump Inhibitors